Botulinum neurotoxin A: An unusual systemic effect

Journal of Paediatrics and Child Health

Volumn 43, Issue 6, 2007, Pages 499-501

  Howell, Katherine ^a   Selber, Paulo ^a   Graham, H Kerr ^a,b,c   Reddihough, Dinah ^a,b,c  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

Author keywords

Botulinum neurotoxin A; Cerebral palsy; Dysphagia; Stridor

Indexed keywords

ADRENALIN; BOTULINUM TOXIN A; DEXAMETHASONE; NONSTEROID ANTIINFLAMMATORY AGENT;

ARTICLE; BREATHING DISORDER; CASE REPORT; CEREBRAL PALSY; CLINICAL FEATURE; DYSPHAGIA; FEEDING DISORDER; FLUOROSCOPY; HEMATEMESIS; HUMAN; LARYNGOSCOPY; MALE; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; SCHOOL CHILD; SPASTICITY; STRIDOR; VOMITING;

BOTULINUM TOXIN TYPE A; CEREBRAL PALSY; CHILD; DEGLUTITION DISORDERS; HUMANS; MALE; NEUROMUSCULAR AGENTS; PSEUDOBULBAR PALSY; RESPIRATORY SOUNDS;

EID: 34249096755     PISSN: 10344810     EISSN: 14401754     Source Type: Journal    
DOI: 10.1111/j.1440-1754.2007.01122.x     Document Type: Article

References (10)

1. Boyd RN, Graham JEA, Nattrass GR, Graham HK. Medium-term response characterisation and risk factor analysis of botulinum toxin type A in the management of spasticity in children with cerebral palsy. Eur. J. Neurol. 1999 6 (Suppl. 4 S37 45.
2. Ade-Hall RA, Moore AP. Botulinum toxin type A in the treatment of lower limb spasticity in cerebral palsy. Cochrane Database Syst. Rev. 2000 2: CD001408. 10.1002/14651858.CD001408.
3. Bakheit AMO, Severa S, Cosgrove A et al. Safety profile and efficacy of botulinum toxin A in children with muscle spasticity. Dev. Med. Child Neurol. 2001 43: 234 8.
4. Bakheit AM, Ward CD, McLellan DLI. Generalised botulism-like syndrome after intramuscular injections of botulinum toxin type A: a report of 2 cases. J. Neurol. Neurosurg. Psychiatry 1997 62: 198.
5. Bhatia KP, Münchau A, Thompson PD et al. Generalised muscular weakness after botulinum toxin injections for dystonia: a report of three cases. J. Neurol. Neurosurg. Psychiatry 1999 67: 90 3.
6. Carr LJ, Cosgrove AP, Gringras P, Neville BGR. Position paper on the use of botulinum toxin in cerebral palsy. Arch. Dis. Child. 1998 79: 271 3.
7. Graham HK, Aoki KR, Autti-Ramo I et al. Recommendations for the use of Botulinum toxin type A in the management of cerebral palsy. Gait Posture 2000 11: 67 79.
8. Li M, Goldberger BA, Hopkins C. Fatal case of BOTOX-related anaphylaxis? J. Forensic. Sci. 2005 50: 169 72.
9. Molenaers G, Desloovere K, De Cat J et al. Single event multilevel botulinum toxin type A treatment and surgery: similarities and differences. Eur. J. Neurol. 2001 8: 88 97.
10. Heinen F, Molenaers G, Fairhurst C et al. European consensus table 2006 on botulinum toxin for children with cerebral palsy. Eur. J. Paediatr. Neurol. Soc. 2006 10: 215 25.